FUSE MEDICAL, INC.: 10-Q filed 2016-11-14

Name: FUSE MEDICAL, INC.: 10-Q filed 2016-11-14
Creator: FUSE MEDICAL, INC.

What FUSE MEDICAL, INC. reported in its quarterly report filed 2016-11-14 (fiscal Q3 2016): 33 published measures, 82 facts as tagged in accession 0001477932-16-013471.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-11-14
Fiscal period: fiscal Q3 2016
Accession: 0001477932-16-013471 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All FUSE MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-09-30	137,131	USD
At 2015-12-31	435,005	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-09-30	384,108	USD
At 2015-12-31	430,048	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2016-09-30	-246,977	USD
At 2015-12-31	4,957	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-09-30	61,734	USD
At 2015-12-31	8,157	USD
At 2015-09-30	57,160	USD
At 2014-12-31	67,555	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-113,393	USD	92
2016-01-01 to 2016-09-30	-325,684	USD	274
2015-07-01 to 2015-09-30	-480,642	USD	92
2015-01-01 to 2015-09-30	-815,534	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	-46,723	USD	274
2015-01-01 to 2015-09-30	-332,215	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	1,580	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	107,584	USD	92
2016-01-01 to 2016-09-30	421,170	USD	274
2015-07-01 to 2015-09-30	442,857	USD	92
2015-01-01 to 2015-09-30	1,192,718	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	100,000	USD	274
2015-01-01 to 2015-09-30	322,750	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	300	USD	274
2015-01-01 to 2015-09-30	-930	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-09-30	-2,640,728	USD
At 2015-12-31	-2,315,044	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-09-30	12,432	USD
At 2015-12-31	24,978	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	418,000	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-117,086	USD	92
2016-01-01 to 2016-09-30	-324,297	USD	274
2015-07-01 to 2015-09-30	-477,778	USD	92
2015-01-01 to 2015-09-30	-809,207	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-09-30	120,877	USD
At 2015-12-31	406,205	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	1,750	USD	92
2016-01-01 to 2016-09-30	5,250	USD	274
2015-07-01 to 2015-09-30	1,885	USD	92
2015-01-01 to 2015-09-30	5,348	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-09-30	383,284	USD
At 2015-12-31	330,048	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2016-09-30	113,966	USD
At 2015-12-31	295,579	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2016-09-30	22,328	USD
At 2015-12-31	298,011	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2016-09-30	31,591	USD
At 2015-12-31	81,209	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	65,048	USD	92
2016-01-01 to 2016-09-30	276,516	USD	274
2015-07-01 to 2015-09-30	277,589	USD	92
2015-01-01 to 2015-09-30	755,805	USD	273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	42,536	USD	92
2016-01-01 to 2016-09-30	144,654	USD	274
2015-07-01 to 2015-09-30	165,268	USD	92
2015-01-01 to 2015-09-30	436,913	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-09-30	6,890,808	shares
At 2015-12-31	6,890,808	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2016-09-30	2,324,843	USD
At 2015-12-31	2,251,093	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2016-09-30	43,945	USD
At 2015-12-31	59,176	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2016-09-30	-31,513	USD
At 2015-12-31	-34,198	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2016-09-30	14,437	USD
At 2015-12-31	12,267	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2016-09-30	5,224	USD
At 2015-12-31	18,828	USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	3,502	USD	92
2016-01-01 to 2016-09-30	10,666	USD	274
2015-07-01 to 2015-09-30	8,563	USD	92
2015-01-01 to 2015-09-30	21,888	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	3,693	USD	92
2016-01-01 to 2016-09-30	-1,387	USD	274
2015-07-01 to 2015-09-30	-2,864	USD	92
2015-01-01 to 2015-09-30	-6,327	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	275,683	USD	274
2015-01-01 to 2015-09-30	19,209	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	49,618	USD	274
2015-01-01 to 2015-09-30	63,801	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	-146,096	USD	274
2015-01-01 to 2015-09-30	-76,715	USD	273

Inspect the source

Entity: FUSE MEDICAL, INC. / CIK 0000319016
Captured: 2026-09-19T11:14:02.031Z
SEC response SHA-256: 13d41024642d3becfdbc15fe6e31fdae11d4fa7a32679fcba6c1a612c57d756a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000319016.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))